Figma Shares Indicated To Open $95/$100
On March 17, 2025, Robert Fauber, the President and CEO of Moody’s Corp (NYSE:MCO), executed a series of stock transactions, as disclosed in a recent SEC filing. Fauber sold a total of 415 shares of Moody’s common stock, totaling $184,438, at a price of $444.43 per share. The stock currently trades at $450.10, with InvestingPro analysis indicating the stock is trading above its Fair Value. The company, with a market capitalization of $81.12 billion, maintains a P/E ratio of 39.71. These sales were conducted under a Rule 10b5-1 trading plan he adopted on July 30, 2024.
In addition to the sales, Fauber also exercised stock options, acquiring a total of 281 shares at prices ranging from $80.81 to $113.34 per share. The total value of these option exercises amounted to $27,459. Following these transactions, Fauber’s direct ownership in Moody’s stands at 62,957.984 shares.
In other recent news, Moody’s Corporation reported several noteworthy developments. BMO Capital Markets maintained a Market Perform rating for Moody’s, with a price target of $531, citing solid growth prospects for Moody’s Investor Services driven by long-term trends in debt issuance and private credit opportunities. Meanwhile, Mizuho (NYSE:MFG) initiated coverage with a Neutral rating and a $504 target, highlighting Moody’s competitive strengths and potential profitability from technology investments. RBC Capital Markets also kept an Outperform rating with a $550 target, despite revising down MIS revenue estimates due to current market challenges, expressing optimism for a medium-term recovery.
Additionally, Moody’s announced an executive transition, with Jason Phillips set to succeed Caroline Sullivan as Chief Accounting Officer and Controller, effective April 1, 2025. This transition is described as a routine change without underlying issues. In related news, Nutrien (NYSE:NTR) Ltd., a major player in the agriculture chemicals sector, filed its annual report with the SEC, detailing its financial performance and operational highlights. This filing is part of Nutrien’s commitment to transparency and regulatory compliance, ensuring investors have access to comprehensive financial information.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.